Two Sigma Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Sell |
|
|||||
|
2025
Q1 | $1.32M | Buy |
|
|||||
|
2024
Q4 | $474K | Sell |
|
|||||
|
2024
Q3 | $543K | Buy |
|
|||||
|
2024
Q2 | $462K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.44M | Sell |
|
|||||
|
2023
Q2 | $3.38M | Buy |
|
|||||
|
2023
Q1 | $4.01M | Buy |
|
|||||
|
2022
Q4 | $15.2M | Buy |
|
|||||
|
2022
Q3 | $11.1M | Buy |
|
|||||
|
2022
Q2 | $8.97M | Buy |
|
|||||
|
2022
Q1 | $4.21M | Buy |
|
|||||
|
2021
Q4 | $5.1M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.34M | Sell |
|
|||||
|
2020
Q4 | $3.89M | Sell |
|
|||||
|
2020
Q3 | $6.49M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $112K | Buy |
|